NICOLÁS
MENDOZA LADRÓN DE GUEVARA

CATEDRÁTICO DE UNIVERSIDAD

Foto de NICOLÁS

Foto de Daniel María

Daniel María
Lubián López

Daniel María Lubián López-rekin lankidetzan egindako argitalpenak (7)

2024

Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis
Menopause (New York, N.Y.), Vol. 31, Núm. 3, pp. 234-242

2022

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group
Maturitas, Vol. 166, pp. 65-85

2021

Relationship of breast volume, obesity and central obesity with different prognostic factors of breast cancer
Scientific Reports, Vol. 11, Núm. 1
Sexual dysfunction in postmenopausal women with breast cancer on adjuvant aromatase inhibitor therapy
Breast Care, Vol. 16, Núm. 4, pp. 376-382

2019

Metabolic syndrome and prognostic factors in postmenopausal breast cancer patients
Breast Journal

2018

Aeem-sego position statement on menopausal hormone therapy
Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 230-234

2017

Recommendations of the Spanish Menopause Society on the consumption of omega-3 polyunsaturated fatty acids by postmenopausal women
Maturitas, Vol. 103, pp. 71-77